Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06306521 · ClinicalTrials.gov registry record · NA
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
A NA study of Genetic Disease, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 10,000
- Enrollment target
- 1
- Study location
NCT06306521 is a NA study of Genetic Disease that is actively recruiting participants, run by Rady Pediatric Genomics & Systems Medicine Institute. The registered enrollment target is 10,000 participants, above the 2,228-participant average among 30 other Genetic Disease trials with a reported enrollment target (349% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06306521, a NA study of Genetic Disease, is actively recruiting participants, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test a new method for newborn screening using whole genome sequencing, called BeginNGS. Parents will be approached to provide informed consent to enroll their newborns in prenatal, postnatal, and outpatient settings. The main questions this study aims to answer are: What is the utility of BeginNGS as compared to state newborn screening? What is the acceptability and feasibility of BeginNGS as compared to state newborn screening? What is the cost effectiveness of BeginNGS as compared to state newborn screening? Enrolled newborns will have a blood sample taken and will receive the BeginNGS test. Newborns will have also had the state newborn screening test.
Conditions Studied
Interventions
- GENETIC BeginNGS Test
Study Locations (1)
California
- Rady Children's Hospital San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2024-02-29 |
| Est. Completion | 2029-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06306521
The ClinicalTrials.gov registry entry for NCT06306521 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,228-participant average among 30 other Genetic Disease trials with a reported enrollment target (349% higher). The listed sponsor is Rady Pediatric Genomics & Systems Medicine Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which BeginNGS Test is the first listed.
NCT06306521 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06306521 about?
NCT06306521 is a clinical study titled "An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing". The goal of this clinical trial is to test a new method for newborn screening using whole genome sequencing, called BeginNGS. Parents will be approached to provide informed consent to enroll their newborns in prenatal, postnatal, and outpatient settings. The main questions this study aims to answer ...
What is the current status of trial NCT06306521?
This trial is currently recruiting. It is a NA study. The enrollment target is 10,000 participants. The study started on 2024-02-29. Estimated completion is 2029-02.
What conditions does trial NCT06306521 study?
This clinical trial studies the following conditions: Genetic Disease.
What interventions are being tested in trial NCT06306521?
The interventions under investigation include: BeginNGS Test (GENETIC).
Who is sponsoring clinical trial NCT06306521?
This trial is sponsored by Rady Pediatric Genomics & Systems Medicine Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06306521 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Large Language Models To Improve the Quality of Care of Cardiology Patients
RECRUITING · NA
-
Grand Valley State University (GVSU) Skills on Wheels
ACTIVE NOT RECRUITING · NA
-
Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
ACTIVE NOT RECRUITING · NA
-
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.